Fresenius Price Sales Ratio from 2010 to 2024

FMS Stock  USD 20.93  0.44  2.06%   
Fresenius Medical Price Sales Ratio yearly trend continues to be comparatively stable with very little volatility. Price Sales Ratio will likely drop to 0.28 in 2024. From the period from 2010 to 2024, Fresenius Medical Price Sales Ratio quarterly data regression had r-value of (0.91) and coefficient of variation of  53.56. View All Fundamentals
 
Price Sales Ratio  
First Reported
2010-12-31
Previous Quarter
0.28995769
Current Value
0.28
Quarterly Volatility
0.54907628
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Fresenius Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Fresenius Medical's main balance sheet or income statement drivers, such as Interest Expense of 234.9 M, Total Revenue of 11.4 B or Gross Profit of 3.7 B, as well as many indicators such as Price To Sales Ratio of 0.28, Dividend Yield of 0.0612 or PTB Ratio of 0.39. Fresenius financial statements analysis is a perfect complement when working with Fresenius Medical Valuation or Volatility modules.
  
Check out the analysis of Fresenius Medical Correlation against competitors.

Latest Fresenius Medical's Price Sales Ratio Growth Pattern

Below is the plot of the Price Sales Ratio of Fresenius Medical Care over the last few years. It is Fresenius Medical's Price Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Fresenius Medical's overall financial position and show how it may be relating to other accounts over time.
Price Sales Ratio10 Years Trend
Slightly volatile
   Price Sales Ratio   
       Timeline  

Fresenius Price Sales Ratio Regression Statistics

Arithmetic Mean1.03
Geometric Mean0.84
Coefficient Of Variation53.56
Mean Deviation0.50
Median1.41
Standard Deviation0.55
Sample Variance0.30
Range1.3793
R-Value(0.91)
Mean Square Error0.06
R-Squared0.83
Slope(0.11)
Total Sum of Squares4.22

Fresenius Price Sales Ratio History

2024 0.28
2023 0.29
2022 0.23
2021 0.47
2020 0.56
2019 0.57
2018 1.05

About Fresenius Medical Financial Statements

Fresenius Medical shareholders use historical fundamental indicators, such as Price Sales Ratio, to determine how well the company is positioned to perform in the future. Although Fresenius Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Fresenius Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Fresenius Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Price Sales Ratio 0.29  0.28 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Fresenius Stock Analysis

When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.